CHD4 and dermatomyositis: The CHD3 (chromodomain-helicase-DNA-binding 3) (or Mi-2α) and CHD4 (or Mi-2β) proteins were originally identified as autoantigens in dermatomyositis, a connective tissue disease, which imparts an increased risk of malignancy [1–3].